Role of AI in determining treatment options and managing patients with resectable PDAC [Video]

Nelson Dusetti, PhD, Cancer Research Centre of Marseille, Marseille, France, discusses the potential role artificial intelligence (AI) could have in determining treatment options and managing patients with resectable pancreatic ductal adenocarcinoma (PDAC). This interview took place during the 2024 American Society of Clinical Oncology (ASCO) Meeting in Chicago, IL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.